Correction to: Effect of Renal Impairment on Pharmacokinetics and Safety of Ensitrelvir, a SARS‑CoV‑2 3CL Protease Inhibitor
- PMID: 39136875
- PMCID: PMC11343925
- DOI: 10.1007/s40121-024-01030-0
Correction to: Effect of Renal Impairment on Pharmacokinetics and Safety of Ensitrelvir, a SARS‑CoV‑2 3CL Protease Inhibitor
Erratum for
-
Effect of Renal Impairment on Pharmacokinetics and Safety of Ensitrelvir, a SARS-CoV-2 3CL Protease Inhibitor.Infect Dis Ther. 2024 Mar;13(3):597-607. doi: 10.1007/s40121-024-00946-x. Epub 2024 Mar 9. Infect Dis Ther. 2024. PMID: 38460082 Free PMC article.
Publication types
LinkOut - more resources
Full Text Sources
Miscellaneous
